CAR-T Therapies will Dominate in 2018 Next Generation BTK Inhibitor data is still early - 100459

Spotlight
Video

CAR-T Therapies will Dominate in 2018 Next Generation BTK Inhibitor data is still early

moasc has 295 videos Subscribe Here

Loading........
Description: Elizabeth Brém, MD - HS Clinical Assistant Professor Chao Comprehensive Cancer Center discusses how CAR-T Therapies will Dominate in 2018 Next Generation BTK Inhibitor data is still early at MOASC’s Spotlight On Hematology in Huntington Beach 2018.
Shared By : moasc
Posted on : 02/06/18
Added : 3 months ago
Category : Lymphoma



Recommended

Nothing found.